Lemonade, Inc. (LMND) Guidance & Earnings Results

On 2026-07-29 Lemonade, Inc. raised guidance: "Q3 2026 and FY 2026 guidance: Q4 Adj. EBITDA positive expected; IFP growth to outpace spend growth in…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

LMNDLemonade, Inc.Follow LMND — free

Insurance - Property & Casualty · Financials

—

Price chart with a free account

Market cap: 3.5B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
29 Jul 26	Raised	Q3 2026 and FY 2026 guidance: Q4 Adj. EBITDA positive expected; IFP growth to outpace spend growth in 2027.
19 Feb 26	Raised	IFP growth acceleration for 9 consecutive quarters, revenue +53%, gross profit +73%
5 Nov 25	Raised	FY IFP raised to $1,218-$1,223M; GEP to $1,044-$1,047M; Revenue to $727-$732M; Adj. EBITDA loss improved to ($130)-($127)M · full year
5 Aug 25	Raised	FY2025 IFP raised to $1,213-$1,218M; FY2025 GEP raised to $1,036-$1,039M; FY2025 Revenue raised to $710-$715M; FY2025 Adj. EBITDA loss reiterated at ($140)-($135)M; Q3 2025 IFP $1,144-$1,147M; Q3 2025 GEP $267-$269M; Q3 2025 Revenue $183-$186M; Q3 2025 Adj. EBITDA loss ($37)-($34)M · full year

Lemonade, Inc. — questions

What guidance did Lemonade, Inc. give?: On 2026-07-29: "Q3 2026 and FY 2026 guidance: Q4 Adj. EBITDA positive expected; IFP growth to outpace spend growth in 2027."
When does Lemonade, Inc. report earnings?: Lemonade, Inc.'s next earnings report is expected on 2026-11-05.

Every figure on this page comes from Lemonade, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.